A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis
To assess the changes in the serum concentrations of 25(ОH)D in relapse and remission and their relation to the degree of neurological deficit. We analyzed 53 subjects (30 controls and 23 patients) from October 2012 to Маy 2013. Diagnosis was based on McDonald 2010 criteria. The severity of neurolog...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2014-11-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34332/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849730360569495552 |
|---|---|
| author | Georgi Slavov Maria Manova Anastasiya Trenova Ivanka Kostadinova Pavel Pavlov Nonka Mateva |
| author_facet | Georgi Slavov Maria Manova Anastasiya Trenova Ivanka Kostadinova Pavel Pavlov Nonka Mateva |
| author_sort | Georgi Slavov |
| collection | DOAJ |
| description | To assess the changes in the serum concentrations of 25(ОH)D in relapse and remission and their relation to the degree of neurological deficit. We analyzed 53 subjects (30 controls and 23 patients) from October 2012 to Маy 2013. Diagnosis was based on McDonald 2010 criteria. The severity of neurological deficit was assessed by the Expanded Disability Status Scale. Serum concentrations of 25(ОH)D (nmol/l) were measured by ELISA once in controls and twice in patients - in relapse and remission. Mean levels in all groups were in the mild to moderate deficiency range, being lowest in the patients in relapse (controls 31.46±7.3; relapse 26.93±7.44; remission 28.06±7.28). There was a trend for lower levels of 25(ОH)D in healthy females in comparison to their male counterparts, and in female patients in relapse as compared to males (female controls - 26.56±8.4, male controls - 41.35±11.86; females in relapse - 26.33±10.03, males in relapse - 28.06±11.08). Negative statistically significant correlations between the concentrations of 25(ОH)D during relapse and remission and the degree of neurological deficit in the corresponding period were found (cc. -0.593, Sig 0.03, relapse; -0.46, Sig 0.024, remission). Assessment of the risk for development of MS, regarding the 25(ОH)D showed protective effect with respect to the risk of disease occurrence (ОR: 04125 relapse; 0.578 remission). |
| format | Article |
| id | doaj-art-d0a479c3e4da48d896c75704895a973e |
| institution | DOAJ |
| issn | 1313-9053 |
| language | English |
| publishDate | 2014-11-01 |
| publisher | Medical University - Pleven |
| record_format | Article |
| series | Journal of Biomedical & Clinical Research |
| spelling | doaj-art-d0a479c3e4da48d896c75704895a973e2025-08-20T03:08:55ZengMedical University - PlevenJournal of Biomedical & Clinical Research1313-90532014-11-0171374110.1515/jbcr-2015-012334332A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple SclerosisGeorgi SlavovMaria ManovaAnastasiya TrenovaIvanka KostadinovaPavel PavlovNonka MatevaTo assess the changes in the serum concentrations of 25(ОH)D in relapse and remission and their relation to the degree of neurological deficit. We analyzed 53 subjects (30 controls and 23 patients) from October 2012 to Маy 2013. Diagnosis was based on McDonald 2010 criteria. The severity of neurological deficit was assessed by the Expanded Disability Status Scale. Serum concentrations of 25(ОH)D (nmol/l) were measured by ELISA once in controls and twice in patients - in relapse and remission. Mean levels in all groups were in the mild to moderate deficiency range, being lowest in the patients in relapse (controls 31.46±7.3; relapse 26.93±7.44; remission 28.06±7.28). There was a trend for lower levels of 25(ОH)D in healthy females in comparison to their male counterparts, and in female patients in relapse as compared to males (female controls - 26.56±8.4, male controls - 41.35±11.86; females in relapse - 26.33±10.03, males in relapse - 28.06±11.08). Negative statistically significant correlations between the concentrations of 25(ОH)D during relapse and remission and the degree of neurological deficit in the corresponding period were found (cc. -0.593, Sig 0.03, relapse; -0.46, Sig 0.024, remission). Assessment of the risk for development of MS, regarding the 25(ОH)D showed protective effect with respect to the risk of disease occurrence (ОR: 04125 relapse; 0.578 remission).https://jbcr.arphahub.com/article/34332/download/pdf/vitamin Dmultiple sclerosisEDSS |
| spellingShingle | Georgi Slavov Maria Manova Anastasiya Trenova Ivanka Kostadinova Pavel Pavlov Nonka Mateva A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis Journal of Biomedical & Clinical Research vitamin D multiple sclerosis EDSS |
| title | A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis |
| title_full | A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis |
| title_fullStr | A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis |
| title_full_unstemmed | A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis |
| title_short | A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis |
| title_sort | prospective study on 25 hydroxyvitamin d serum levels in patients with relapsing remitting multiple sclerosis |
| topic | vitamin D multiple sclerosis EDSS |
| url | https://jbcr.arphahub.com/article/34332/download/pdf/ |
| work_keys_str_mv | AT georgislavov aprospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT mariamanova aprospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT anastasiyatrenova aprospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT ivankakostadinova aprospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT pavelpavlov aprospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT nonkamateva aprospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT georgislavov prospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT mariamanova prospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT anastasiyatrenova prospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT ivankakostadinova prospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT pavelpavlov prospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis AT nonkamateva prospectivestudyon25hydroxyvitamindserumlevelsinpatientswithrelapsingremittingmultiplesclerosis |